Verbatim response from ChatGPT
Short answer: very likely yes — a BMI of 31 meets the FDA indication for Wegovy (semaglutide) in adults — but you still need a medical evaluation and clearance from a licensed prescriber.
Details and next steps
- FDA criteria: Wegovy is approved for chronic weight management in adults with BMI ≥30, or BMI ≥27 with at least one weight‑related comorbidity (type 2 diabetes, hypertension, high cholesterol, etc.). Your BMI 31 meets the threshold.
- Clinical evaluation required: a prescriber will review your medical history, current medications, pregnancy status (Wegovy is contraindicated in pregnancy), do appropriate labs as needed, and screen for contraindications (personal or family history of medullary thyroid carcinoma or MEN2, history of pancreatitis, certain GI disorders, etc.). They’ll also discuss lifestyle modification and monitoring plans.
- If you have type 2 diabetes: your clinician may consider a different semaglutide product/dose (e.g., Ozempic/Rybelsus used for diabetes) or adjust management accordingly.
Who can prescribe online
- Types of clinicians: board‑certified physicians, nurse practitioners, or physician assistants working through telehealth platforms — particularly primary care, endocrinology, or obesity‑medicine clinicians — can prescribe Wegovy if it’s appropriate after evaluation.
- Common telehealth services that frequently evaluate and (when appropriate) prescribe GLP‑1s like semaglutide: Hims & Hers, Ro (Roman), PlushCare, and GoodRx Care (HeyDoctor). These companies offer online consultations and may prescribe Wegovy or generic semaglutide after a clinical assessment. (Policies and availability vary by state and by patient health history.)
- If you prefer specialty care: look for an obesity medicine specialist (use the American Board of Obesity Medicine directory) or an endocrinologist who offers telemedicine.
Other practical points
- Prior authorization / cost: many insurers require prior authorization for Wegovy; out‑of‑pocket cost can be high. Some telehealth providers may offer generic semaglutide alternatives or programs to help with access.
- Safety: stop and do not start Wegovy if you are pregnant or planning pregnancy; discuss breastfeeding, thyroid cancer risk, pancreatitis history, and other meds with the prescriber.
- What to bring to the telehealth visit: list of current meds, past medical/surgical history (esp. pancreas/thyroid), recent weight and height (to confirm BMI), and insurance info.
If you want, I can:
- Find telehealth providers in your state that offer GLP‑1 prescriptions,
- Help draft the questions to ask during a consult, or
- Look up nearby ABOM‑certified obesity specialists. Which would you prefer?